Benchmark Downgrades Nephros (NEPH) to Hold
Tweet
Share
E-mailGet Alerts NEPH Hot Sheet
Price: $4.36 +2.11%
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Benchmark analyst Robert Wasserman downgraded Nephros (NASDAQ: NEPH) from Speculative Buy to Hold.
For an analyst ratings summary and ratings history on Nephros click here. For more ratings news on Nephros click here.
Shares of Nephros closed at $2.21 yesterday.
You May Also Be Interested In
- Oppenheimer Downgrades Legend Biotech Corp. (LEGN) to Perform, 'CEO/Partnership/Competition Overhangs to Cap Upside'
- BTIG Downgrades Apogee Therapeutics Inc (APGE) to Neutral
- ICICI Securities Downgrades Astra Microwave Products (ASTM:IN) to Hold (3)
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
